Skip to main content
SpringerLink
Log in

Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of the study was to evaluate the outcome of the use of the temporary amniotic membrane patch (TAMP) for the treatment of primary pterygium and to investigate the mechanisms of reducing the recurrence rate.

Methods

Twenty eyes in 20 patients with primary pterygium underwent pterygium excision followed by TAMP for 5 days. Removed amniotic membrane (AM) was immunostained with primary antibodies CD34, c-Kit, STRO-1 and AC133.

Results

Within the period of follow-up (53.3±13.8 months), all the eyes showed a smooth ocular surface without recurrence of pterygium. Different grades of CD34, c-Kit, STRO-1and AC133 positive stem and progenitor cells infiltrated or attached to the stroma of patched AM, with more spindle-shaped c-Kit cells than ovoid-shaped CD34 and AC133 cells.

Conclusion

The temporary amniotic membrane patch is an effective and safe procedure for the treatment of primary pterygium. Absorbing excessive stem and progenitor cells may be one of the mechanisms of reducing the recurrence rate using AM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adamis AP, Starck T, Kenyon KR (1990) The management of pterygium. Ophthalmol Clin North Am 3:611–623

    Google Scholar 

  2. Anderson DM, Lyman SD, Baird A et al (1990) Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63:235–243

    Article  PubMed  CAS  Google Scholar 

  3. Azuara-Blanco A, Pillai CT, Dua HS (1999) Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 83:399–402

    PubMed  CAS  Google Scholar 

  4. Boudreau N, Werb Z, Bissell MJ (1996) Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad Sci U S A 93:3500–3513

    Article  Google Scholar 

  5. Boyd AW (1987) Human leukocyte antigens: an update on structure, function and nomenclature. Pathology 19:329–337

    Article  PubMed  CAS  Google Scholar 

  6. Cameron ME (1983) Histology of pterygium: an electron microscopic study. Br J Ophthalmol 67:604–608

    Article  PubMed  CAS  Google Scholar 

  7. Cano-Parra J, Diaz-Llopis M, Maldonado MJ et al (1995) Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol 79:439–441

    Article  PubMed  CAS  Google Scholar 

  8. Dennis JE, Carbillet JP, Caplan A, Charbord P (2002) The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 170:73–82

    Article  PubMed  Google Scholar 

  9. Dushku N, Reid TW (1994) Immunohistochemical evidence that human pterygia originate from an invasion of vimentin-expressing altered limbal epithelial basal cells. Curr Eye Res 13:473–481

    Article  PubMed  CAS  Google Scholar 

  10. Dushku N, John MK, Schultz GS, Reid TW (2001) Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 119:695–706

    PubMed  CAS  Google Scholar 

  11. Frucht-Pery J, Siganos CS, Ilsar M (1996) Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 103:674–677

    PubMed  CAS  Google Scholar 

  12. Garlanda C, Dejana E (1997) Heterogeneity of endothelial cells: specific markers. Arterioscler Thromb Vasc Biol 17:1193–1202

    PubMed  CAS  Google Scholar 

  13. Gronthos S, Graves SE, Ohta S, Simmons PJ (1994) The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood 84:4164–4173

    PubMed  CAS  Google Scholar 

  14. Guler M, Sobaci G, Ilker S et al (1994) Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol 72:721–726

    Article  CAS  Google Scholar 

  15. Hao YX, Ma DH, Hwang DG et al (2000) Identification of anti-neovascularization proteins in human amniotic membrane. Cornea 19:348–352

    Article  PubMed  CAS  Google Scholar 

  16. Huang E, Nocka K, Beier DR et al (1990) The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225–233

    Article  PubMed  CAS  Google Scholar 

  17. Huss R, Moosmann S (2002) The co-expression of CD117 (c-kit) and osteocalcin in activated bone marrow stem cells in different diseases. Br J Haematol 118:305–312

    Article  PubMed  CAS  Google Scholar 

  18. Kenyon KR, Wagoner MD, Hettinger ME (1985) Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 92:1461–1470

    PubMed  CAS  Google Scholar 

  19. Kim JC, Tseng SCG (1995) The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J Ophthalmol 9:32–46

    PubMed  CAS  Google Scholar 

  20. Kim JC, Tseng SCG (1995) Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14:472–484

    Article  Google Scholar 

  21. Kim JS, Kim JC, Hahn TW, Park WC (2001) Amniotic membrane transplantation in infectious corneal ulcer. Cornea 20:720–726

    Article  PubMed  CAS  Google Scholar 

  22. Kobayashi N, Kabuyama Y, Sasaki S et al (2002) Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 21:62–67

    Article  PubMed  Google Scholar 

  23. Lam DS, Wong AK, Fan DS et al (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105:901–904

    Article  PubMed  CAS  Google Scholar 

  24. Lee SB, Li DQ, Tan DT et al (2000) Suppression of TGF-beta signaling in both normal conjunctival fibroblasts and pterygial body fibroblasts by amniotic membrane. Curr Eye Res 20:325–334

    Article  PubMed  CAS  Google Scholar 

  25. Mahar PS, Nwokora GE (1993) Role of mitomycin C in pterygium surgery. Br J Ophthalmol 77:433–435

    Article  PubMed  CAS  Google Scholar 

  26. Miraglia S, Godfrey W, Yin AH et al (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90:5013–5021

    PubMed  CAS  Google Scholar 

  27. Monselise M, Schwartz M, Politi F, Barishak YR (1984) Pterygium and beta irradiation. Acta Ophthalmol (Copenh) 62:315–319

    CAS  Google Scholar 

  28. Peault BM, Thiery JP, LeDouarin NM (1983) Surface marker for hemopoietic and endothelial cell lineages that is defined by monoclonal antibody. Proc Natl Acad Sci U S A 80:2976–2980

    Article  PubMed  CAS  Google Scholar 

  29. Prabhasawat P, Barton K, Burkett G, Tseng SCG (1997) Comparson of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision. Ophthalmology 104:974–985

    PubMed  CAS  Google Scholar 

  30. Schlingemann RO, Rietveld FJ, de Waal RM et al (1990) Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 62:690–696

    PubMed  CAS  Google Scholar 

  31. Schmeisser A, Strasser RH (2002) Phenotypic overlap between hematopoietic cells with suggested angioblastic potential vascular endothelial cells. J Hematother Stem Cell Res 11:69–79

    Article  PubMed  CAS  Google Scholar 

  32. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K (2001) Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20:408–413

    Article  PubMed  CAS  Google Scholar 

  33. Simmons PJ, Torok SB (1991) Identification of stroma cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55–62

    PubMed  CAS  Google Scholar 

  34. Solomon A, Pires RT, Tseng SCG (2001) Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 101:449–460

    Article  Google Scholar 

  35. Tan DT, Chee SP, Dear KB, Lim AS (1997) Effect of pterygium morphology on pterygium recurrence in controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235–1240

    PubMed  CAS  Google Scholar 

  36. Tan DT, Lim AS, Goh HS, Smith DR (1997) Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 123:404–405

    PubMed  CAS  Google Scholar 

  37. Tananuvat N, Martin T (2004) The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 23:458–463

    Article  PubMed  Google Scholar 

  38. Tseng SCG, Prabhasawat P, Lee SH (1997) Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 104:2068–2076

    PubMed  Google Scholar 

  39. Tseng SCG, Li DG, Ma X (1999) Suppression of transforming growth factor-beta isoforms, TGF-B receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblast by amniotic membrane matrix. J Cell Physiol 179:325–335

    Article  PubMed  CAS  Google Scholar 

  40. Watt SM, Karhi K, Gatter K et al (1987) Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1:417–426

    PubMed  CAS  Google Scholar 

  41. Ye J, Song YS, Kang SH et al (2004) Involvement of bone marrow-derived stem and progenitor cells in the pathogenesis of pterygium. Eye 18:839–843

    Article  PubMed  CAS  Google Scholar 

  42. Yin AH, Miraglia S, Zanjani ED et al (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002–5012

    PubMed  CAS  Google Scholar 

  43. Zsebo KM, Williams DA, Geissler EN et al (1990) Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213–224

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We acknowledge Prof. Jae Chan Kim for his kind direction and great contribution to this research work.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, 2nd Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, People's Republic of China

    Juan Ye & Ke Yao

  2. Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, South Korea

    Juan Ye & Koung Hoon KooK

Authors
  1. Juan Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koung Hoon KooK
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ke Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ke Yao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, J., KooK, K.H. & Yao, K. Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate. Graefe's Arch Clin Exp Ophthalmo 244, 583–588 (2006). https://doi.org/10.1007/s00417-005-0123-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-005-0123-3

Keywords

Search

Navigation